ConductScience.org, home

Paper36878377

Dual transgene amelioration of Lama2-null muscular dystrophy.

McKee KK and 1 other. Matrix Biol, 2023. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Dual transgene amelioration of Lama2-null muscular dystrophy. Papers, record 36878377. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36878377

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dual transgene amelioration of Lama2-null muscular dystrophy.
PubMed
Journal
Matrix Biol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.55
iCite
Revised in PubMed
2024-01-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McKee KKKaren K
2Yurchenco PDPeter D

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Muscle, SkeletalMajor topic
Muscular DystrophiesMajor topic
Mice
Animals
Laminin
Mice, Transgenic
Transgenes

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 DK036425NIDDK NIH HHSUnited StatesR01DK036425PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111565031An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.Nature2001https://conductscience.org/library/papers/11565031PubMed
216413178Ligand-binding specificities of laminin-binding integrins: a comprehensive survey of laminin-integrin interactions using recombinant alpha3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins.Matrix Biol2006https://conductscience.org/library/papers/16413178PubMed
312609502Laminin alpha2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice.Neuromuscul Disord2003https://conductscience.org/library/papers/12609502PubMed
411856301Domain IV of mouse laminin beta1 and beta2 chains.Eur J Biochem2002https://conductscience.org/library/papers/11856301PubMed
58491180A single EGF-like motif of laminin is responsible for high affinity nidogen binding.EMBO J1993https://conductscience.org/library/papers/8491180PubMed
618430779A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination.J Cell Sci2008https://conductscience.org/library/papers/18430779PubMed
715699217Coordinate control of axon defasciculation and myelination by laminin-2 and -8.J Cell Biol2005https://conductscience.org/library/papers/15699217PubMed
820657839Distinct roles for laminin globular domains in laminin alpha1 chain mediated rescue of murine laminin alpha2 chain deficiency.PLoS One2010https://conductscience.org/library/papers/20657839PubMed
922767514Schwann cell myelination requires integration of laminin activities.J Cell Sci2012https://conductscience.org/library/papers/22767514PubMed
1020544910Transgenic overexpression of laminin alpha1 chain in laminin alpha2 chain-deficient mice rescues the disease throughout the lifespan.Muscle Nerve2010https://conductscience.org/library/papers/20544910PubMed
119326364Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy.FEBS Lett1997https://conductscience.org/library/papers/9326364PubMed
1228714989Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism.Nat Med2017https://conductscience.org/library/papers/28714989PubMed
1319189961Scaffold-forming and Adhesive Contributions of Synthetic Laminin-binding Proteins to Basement Membrane Assembly.J Biol Chem2009https://conductscience.org/library/papers/19189961PubMed
1414607975Characterization of the ligand-binding specificities of integrin alpha3beta1 and alpha6beta1 using a panel of purified laminin isoforms containing distinct alpha chains.J Biochem2003https://conductscience.org/library/papers/14607975PubMed
1510842354Form and function: the laminin family of heterotrimers.Dev Dyn2000https://conductscience.org/library/papers/10842354PubMed
169396756Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice.J Cell Biol1997https://conductscience.org/library/papers/9396756PubMed
1710545049Distribution of ten laminin chains in dystrophic and regenerating muscles.Neuromuscul Disord1999https://conductscience.org/library/papers/10545049PubMed
1832848593LAMA2-Related Dystrophies: Clinical Phenotypes, Disease Biomarkers, and Clinical Trial Readiness.Front Mol Neurosci2020https://conductscience.org/library/papers/32848593PubMed
198349613Self-assembly and calcium-binding sites in laminin. A three-arm interaction model.J Biol Chem1993https://conductscience.org/library/papers/8349613PubMed
2030055037LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin-α2 variome and its related phenotypes.Hum Mutat2018https://conductscience.org/library/papers/30055037PubMed

See all 46 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
39213089A Multicenter Cross-Sectional Study of the Swiss Cohort of LAMA2-Related Muscular Dystrophy.J Neuromuscul Dis2024https://conductscience.org/library/papers/39213089PubMed
38678519Molecular mechanisms and therapeutic strategies for neuromuscular diseases.Cell Mol Life Sci2024https://conductscience.org/library/papers/38678519PubMed
37661921Alignment, cross linking, and beyond: a collagen architect's guide to the skeletal muscle extracellular matrix.Am J Physiol Cell Physiol2023https://conductscience.org/library/papers/37661921PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
LAMA23908PubTator's text mininghttps://conductscience.org/library/genes/3908NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36878377

GET https://conductscience.org/api/papers/v1/36878377/references?page=2